American Journal of Cardiology
Volume 106, Issue 6 , Pages 780-786 , 15 September 2010

Long-Term Prognostic Value of Cardiac Troponin I and T Versus Creatine Kinase-MB Mass After Cardiac Surgery in Low-Risk Patients with Stable Symptoms

  • Kjell Vikenes, MD, PhD

      Affiliations

    • Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
    • Corresponding Author InformationCorresponding author: Tel: (+047) 55-97-2220; fax: (+047) 55-97-5150
    • ,
  • Knut S. Andersen, MD, PhD

      Affiliations

    • Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
    • ,
  • Tor Melberg, MD

      Affiliations

    • Stavanger University Hospital, Stavanger, Norway
    • ,
  • Mikael Farstad, MD, PhD

      Affiliations

    • Department of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway
    • ,
  • Jan Erik Nordrehaug, MD, PhD

      Affiliations

    • Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
    • Institute of Medicine, University of Bergen, Bergen, Norway

Received 26 January 2010 ,Accepted 23 April 2010.

References 

  1. Vikenes K, Andersen KS, Melberg T, Farstad M, Nordrehaug JE. Long time prognostic value of CK-MB mass in low-risk patients with stable angina scheduled for cardiac surgery. Cardiology. 2009;113:122–131
  2. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction: universal definition of myocardial infarction. Circulation. 2007;116:2634–2653
  3. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230–236
  4. Vikenes K, Farstad M, Nordrehaug JE. Serotonin is associated with coronary artery disease and cardiac events. Circulation. 1999;100:483–489
  5. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969
  6. Larue C, Calzolari C, Bertinchant JP, Leclercq F, Grolleau R, Pau B. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem. 1993;39:972–979
  7. Hetland Ø, Gøransson L, Nilsen DWT. Cardiac troponin T immunoassay on biotin-streptavidin-coated microplates: preliminary performance in acute myocardial infarction. Scand J Clin Lab Invest. 1995;55:701–713
  8. Prineas RJ, Crowe RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Bristol: John Wright. 1982;203
  9. Klatte K, Chaitman BR, Theroux P, Gavard GA, Boyce S, Bartels C, et al. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release. J Am Coll Cardiol. 2001;38:1070–1077
  10. Costa MA, Lichtenstein SV, Foley DP, de Valk V, Roose PCH, van Geldorp TR, et al. Incidence, predictors, and significance of Abnormal Cardiac Enzyme Rise in Patients Treated with Bypass Surgery in the Arterial Revascularization Therapies Study (ARTS). Circulation. 2001;104:2689–2693
  11. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutaneous or surgical revascularisation and three-year mortality. J Am Coll Cardiol. 2002;40:1961–1967
  12. Steuer J, Hörte L-G, Lindahl B, Ståhle E. Impact of perioperative myocardial injury on early and long-term outcome after coronary artery bypass grafting. Eur Heart J. 2002;23:1219–1227
  13. Newall N, Oo AY, Palmer ND, Grayson AD, Hine TJ, Stables RH, et al. Intermediate and high perioperative cardiac enzyme release following isolated coronary artery bypass surgery are independently associated with higher one-year mortality. J Cardiothorac Surg. 2006;1:20
  14. Petaja L, Salmenpera M, Pulkki K, Pettila V. Biochemical injury markers and mortality after coronary artery bypass grafting: A systematic review. Ann Thorac Surg. 2009;87:1981–1992
  15. Adams JE, Bodor GS, Davila-Roman VG, Delmez JA, Apple FS, Ladenson JH, et al. Cardiac troponin I, a marker with high specificity for cardiac injury. Circulation. 1993;88:101–106
  16. Adams JE, Schectman KB, Landt Y, Ladenson JH, Jaffe AS. Comparable detection of acute infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem. 1994;40:1291–1295
  17. Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem. 1995;41:1266–1272
  18. Vikenes K, Andersen KS, Farstad M, Nordrehaug JE. Temporal pattern of cardiac troponin I after thoracotomy and lung surgery. Int J Cardiol. 2004;96:403–407
  19. Feng YJ, Chen C, Fallon JT, Knibbs DR, Waters DD, Wu AH. Comparison of cardiac troponin I, creatine kinase-CK, and myoglobin for detection of acute ischemic myocardial injury in a swine model. Am J Clin Pathol. 1998;110:70–77
  20. Sabatine MS, Morrow DA, De Lemos JA, Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI. 35 Eur Heart J. 2009;30:162–169

PII: S0002-9149(10)01034-9

doi: 10.1016/j.amjcard.2010.04.038

American Journal of Cardiology
Volume 106, Issue 6 , Pages 780-786 , 15 September 2010

Article Tools

* Image Usage & Resolution